Important problems in the diagnosis and treatment of autoimmune hepatitis (based on the Russian consensus 2017)

E V Vinnitskaya; Yu G Sandler; I G Bakulin; A I Parfenov; L Yu Ilchenko; I G Nikitin; A O Bueverov; T N Lopatkina; Т М Ignatova; V Ye Syutkin; K L Raikhelson; S G Khomeriki; R B Gudkova

doi:10.26442/terarkh201890212-18

Important problems in the diagnosis and treatment of autoimmune hepatitis (based on the Russian consensus 2017)

Ter Arkh. 2018 Feb 15;90(2):12-18. doi: 10.26442/terarkh201890212-18.

Authors

Affiliations

¹ S.A. Loginov Moscow Clinical Research and Practical Center, Moscow Healthcare Department, Moscow, Russia.
² I.I. Mechnikov North-Western state medical University, Ministry of Health of Russia, St. Petersburg, Russia.
³ N.I. Pirogov Russian National Research Medical University, Ministry of Health of Russia, Moscow, Russia.
⁴ I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenovskiy University), Moscow, Russia.
⁵ N.V. Sklifosovskiy Research Institute of Emergency Medicine, Moscow, Russia.
⁶ Saint Petersburg state University, St. Petersburg, Russia.

PMID: 30701766
DOI: 10.26442/terarkh201890212-18

Abstract

The analysis of publications devoted to the Russian Consensus on the Diagnostic and Treatment of Autoimmune Hepatitis (AIH), which was considered at the 43rd annual Scientific Session of the CNIIG From Traditions to Innovation (March 4, 2017) is carried out. The presence of clear algorithms and recommendations for the diagnosis and treatment of AIH significantly help the doctor in real clinical practice, but do not exclude a personified approach to the patient.

Keywords: autoimmune hepatitis; azathioprine; budesonide; immunosuppressive therapy; liver biopsy; prednisolone; pregnancy of pa- tients.

Publication types

Review

MeSH terms

Consensus
Drug Therapy, Combination
Hepatitis, Autoimmune* / diagnosis
Hepatitis, Autoimmune* / therapy
Humans
Immunosuppressive Agents* / therapeutic use
Russia

Substances

Immunosuppressive Agents